Cohance Lifesciences shares have advanced in four of the past seven sessions and is now attempting to recover its losses for 2026. The key level to watch is ₹528, which the stock had touched on December 31, 2025.
Cohance Lifesciences shares have advanced in four of the past seven sessions and is now attempting to recover its losses for 2026. The key level to watch is ₹528, which the stock had touched on December 31, 2025.